Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs nVent Electric (NVT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs nVent Electric — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $112.3 (market cap $12.58B), while nVent Electric trades at $167.69 (market cap $26.58B). The key difference: nVent Electric is far larger — about 2.1× Halozyme Therapeutics Inc. Common Stock's market cap, and nVent Electric pays a 0.51% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and nVent Electric for 11 Days on average.
| HALO | NVT | |
|---|---|---|
Market Cap | $12.58B | $26.58B |
Volume | 2,179,278 | 2,520,678 |
Sector | Health | Industrials |
52-Week High | $115.22 | $184.34 |
52-Week Low | $61.63 | $94.99 |
Typical Hold Time | 0 Days | 11 Days |
Enterprise Value | $14.49B | $27.95B |
Dividend Yield | — | 0.51% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About nVent Electric
nVent provides electrical connection and protection solutions, including enclosures, fastening systems, and thermal management products. Its products help support electrical and industrial infrastructure across multiple end markets.
Read more on NVT →
